India Infection Control Human and Animal Health Market

ID: MRFR/HC/51635-HCR
200 Pages
Rahul Gotadki
Last Updated: March 28, 2026
India Infection Control for the Human Animal Health Market Research Report: Size, Share, Trend Analysis By Product (Disinfection Products, Personal Protective Equipment (PPE), Sterilization Equipment), By Infection Type (Viral, Bacterial, Parasitic, Fungal Infections) and By End Users (Human Healthcare Facilities, Animal Healthcare Facilities) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Infection Control Human and Animal Health Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)7.39%
2024 Market Size$ 0.52 Billion
2025 Market Size$ 0.56 Billion
2035 Market Size$ 1.13 Billion

Key Players

Boehringer Ingelheim
Zoetis
Merck Animal Health
Elanco Animal Health
Virbac
Heska Corporation
Trends
  • Rising Awareness of Zoonotic Diseases
  • Technological Advancements in Infection Control
  • Collaborative Efforts Among Stakeholders
Opportunities
  • Increasing Government Regulations
  • Rising Public Awareness and Education
  • Growing Demand for Veterinary Services
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Disinfection
      2. 4.1.2 Sanitization
      3. 4.1.3 Sterilization
      4. 4.1.4 Antiseptic
      5. 4.1.5 Decontamination
    2. 4.2 Healthcare, BY End Use (USD Billion)
      1. 4.2.1 Veterinary Clinics
      2. 4.2.2 Animal Hospitals
      3. 4.2.3 Research Laboratories
      4. 4.2.4 Livestock Farms
      5. 4.2.5 Pet Care Facilities
    3. 4.3 Healthcare, BY Product Type (USD Billion)
      1. 4.3.1 Chemical Disinfectants
      2. 4.3.2 Biological Disinfectants
      3. 4.3.3 Surface Disinfectants
      4. 4.3.4 Hand Sanitizers
      5. 4.3.5 Personal Protective Equipment
    4. 4.4 Healthcare, BY Distribution Channel (USD Billion)
      1. 4.4.1 Online Retail
      2. 4.4.2 Pharmaceutical Distributors
      3. 4.4.3 Veterinary Supply Stores
      4. 4.4.4 Direct Sales
      5. 4.4.5 Wholesale
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boehringer Ingelheim (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Zoetis (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Merck Animal Health (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Elanco Animal Health (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Virbac (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Heska Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cegelec (FR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Vetoquinol (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Indo American Hybrid Seeds (IN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 INDIA MARKET ANALYSIS BY APPLICATION
    3. 6.3 INDIA MARKET ANALYSIS BY END USE
    4. 6.4 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    5. 6.5 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    14. 6.14 HEALTHCARE, BY END USE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    16. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    18. 6.18 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY END USE, 2026-2035 (USD Billion)
      3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Billion)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

India India Infection Control Human and Animal Health Market Segmentation

India Infection Control Human and Animal Health Market By Application (USD Billion, 2026-2035)

  • Disinfection
  • Sanitization
  • Sterilization
  • Antiseptic
  • Decontamination

India Infection Control Human and Animal Health Market By End Use (USD Billion, 2026-2035)

  • Veterinary Clinics
  • Animal Hospitals
  • Research Laboratories
  • Livestock Farms
  • Pet Care Facilities

India Infection Control Human and Animal Health Market By Product Type (USD Billion, 2026-2035)

  • Chemical Disinfectants
  • Biological Disinfectants
  • Surface Disinfectants
  • Hand Sanitizers
  • Personal Protective Equipment

India Infection Control Human and Animal Health Market By Distribution Channel (USD Billion, 2026-2035)

  • Online Retail
  • Pharmaceutical Distributors
  • Veterinary Supply Stores
  • Direct Sales
  • Wholesale

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035